| Application no. and date | 99942350.2 (espacenet) (Federated) (European Patent Register), 19990819 | | Patent/reg. no. and date | DK/EP 1059933, 20030115 | | Publication date | 20001220 | | Priority no. and date | US 97151 P, 19980819, US 99746 P, 19980910 | | EP pub. no. and date |
EP 1059933 20001220 | | Effective date | | | Applicant/owner | Eli Lilly & Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | 34069 DK 01 | | Inventor | HOCK, Janet, M., 7702 Candlewood Lane
Indianapolis, IN 46250, US,
GAICH, Gregory A., 5744 N.Delaware Street
Indianapolis, IN 46220, US,
DERE, Willard H., 5308 Longstone Roundabout
Carmel, IN 46033, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 38/29 (2006.01) , A61K 31/59 (2006.01) , A61K 33/06 (2006.01) , A61K 38/29 (2006.01) , A61K 38/29 (2006.01) , A61P 19/08 (2006.01) | | Title | Anvendelse af parathyroideahormon bestående af aminosyresekvens 1-34 af humant parathyroideahormon til reduktion af risikoen for både hvirvel- og ikke-hvirvel knoglefraktur | | Int. application no. | US1999018961 | | Int. publication no. | WO2000010596 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
